Skip to content

Joseph Magluilo

Armed Forces Institute of Pathology

2 papers in the library · 54 citations · publishing 2000-2008

Papers

Liquid Chromatography-Electrospray Ionization Mass Spectrometry for the Detection of Lysergide and a Major Metabolite, 2-Oxo-3-Hydroxy-LSD, in Urine and Blood

Journal of Analytical Toxicology October 1, 2000 J. H. Sklerov, Joseph Magluilo, K. K. Shannon et al. 30 citations

A method measures LSD and its metabolite O-H-LSD in urine and blood. O-H-LSD appears in urine at concentrations many times higher than LSD, extending detection time for confirming LSD use. A single-step liquid-liquid extraction on 5-mL urine samples precedes liquid chromatography with electrospray ionization mass spectrometry. Detection limits are 400 pg/mL for O-H-LSD and 100 pg/mL for LSD. In nine LSD-positive urine samples, mean O-H-LSD concentration was 6378 pg/mL (range 332-21371 pg/mL) and mean LSD concentration was 844 pg/mL (range 177-2456 pg/mL), with O-H-LSD levels 0.9 to 19.8 times higher than LSD (mean 10.2). No O-H-LSD was detected in blood samples. Enzymatic hydrolysis of six urine samples showed no significant difference, indicating absence of glucuronic acid conjugation.

The detection and quantitative analysis of the psychoactive component of Salvia divinorum, salvinorin A, in human biological fluids using liquid chromatography-mass spectrometry.

Journal of analytical toxicology January 1, 2008 Pamela C Mcdonough, Justin M Holler, Shawn P Vorce et al. 24 citations

A new analytical method using solid-phase extraction with liquid chromatography-electrospray ionization mass spectrometry accurately detects and quantifies the psychoactive compound salvinorin A in human blood and urine. The method reliably measures concentrations between 5.0 and 100 ng/mL, with a detection limit of 2.5 ng/mL and a quantitation limit of 5.0 ng/mL. It provides a robust tool for forensic toxicology to identify salvinorin A in biological fluids, addressing the lack of published methods and supporting research on the compound's health effects and pharmacokinetics.